Physiol Rev
The scientific record corrected itself in slow motion while the molecule shipped in fast envelopes, and the press-release number outlived the IPO, the trial, and the papers that were eventually pulled
Theyre not just passive hydrators, theyre active participants in your skins healing process
Decide whether to continue, adjust, or complete the protocol
Quick Takeaways Retatrutide is a triple-receptor agonist (GLP-1, GIP, glucagon) delivering superior monotherapy weight loss at 2428.7% over 4868 weeks Cagrilintide targets amylin receptors for satiety and gastric emptying, achieving 10.8% weight loss in 26 weeks as a monotherapy Retatrutide provides broader metabolic benefits, including dramatic improvements in HbA1c, blood pressure, waist circumference, insulin sensitivity, and liver fat normalization No head-to-head trials exist yet, but the mechanistic and clinical data strongly favor Retatrutide for total body recomposition Retatrutide vs Cagrilintide: Side-by-Side Comparison What Makes Retatrutide Different Retatrutide isnt just another GLP-1 receptor agonist
Supplementing AHK-Cu helps restore these biological processes, promoting youthful skin, stronger hair, and improved cellular repair